KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Globus Medical (GMED) Amortization - Intangibles (2016 - 2025)

Historic Amortization - Intangibles for Globus Medical (GMED) over the last 11 years, with Q3 2025 value amounting to $29.8 million.

  • Globus Medical's Amortization - Intangibles fell 77.47% to $29.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $136.2 million, marking a year-over-year decrease of 1605.71%. This contributed to the annual value of $215.4 million for FY2024, which is 20063.08% up from last year.
  • As of Q3 2025, Globus Medical's Amortization - Intangibles stood at $29.8 million, which was down 77.47% from $30.2 million recorded in Q2 2025.
  • In the past 5 years, Globus Medical's Amortization - Intangibles ranged from a high of $53.7 million in Q1 2024 and a low of $4.3 million during Q3 2022
  • Moreover, its 5-year median value for Amortization - Intangibles was $4.8 million (2021), whereas its average is $18.8 million.
  • In the last 5 years, Globus Medical's Amortization - Intangibles surged by 106648.55% in 2024 and then tumbled by 4633.5% in 2025.
  • Globus Medical's Amortization - Intangibles (Quarter) stood at $4.6 million in 2021, then decreased by 1.1% to $4.5 million in 2022, then skyrocketed by 981.82% to $48.7 million in 2023, then decreased by 2.92% to $47.3 million in 2024, then plummeted by 36.94% to $29.8 million in 2025.
  • Its last three reported values are $29.8 million in Q3 2025, $30.2 million for Q2 2025, and $28.8 million during Q1 2025.